Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms
This document reports long-term follow-up results from the TAM-01 breast neoplasms trial and a pooled analysis of low-dose tamoxifen in non-…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer [NA]
A Massachusetts General Hospital study is recruiting older adults with breast cancer to investigate chemotherapy-induced cognitive and brain…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update for a combination of anastrozole, fulvestrant, and abemaciclib in HR-positive, HER2-negative metasta…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating E7090 as a monotherapy and in combination with other anticancer agents in ER-positive, HER2-negative recurrent/meta…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Breathwork App for Cancer Survivors [NA]
A completed clinical trial evaluated a Breathwork app for breast cancer survivors; results were posted on 2026-03-11.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer [Phase 3]
Phase III trial update evaluating SHR-A1811 with or without pertuzumab in HER2-positive breast cancer that is recurrent or metastatic; study…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life
This clinical trial update reports on ongoing research evaluating scapulohumeral comfort, aesthetics, and quality of life in breast cancer p…
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer [Phase 1]
A Phase 1 study evaluating intratumoral influenza vaccine administration in patients with breast cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
Long-term follow-up study of women with early breast cancer who have completed primary treatment; the study is active but not recruiting and…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
This clinical trial update describes the ongoing validation of a blood-based liquid biopsy test for universal early detection of breast canc…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer [Phase 1]
Phase 1 clinical trial update on inavolisib as a single agent and in combination with endocrine and targeted therapies for breast cancer and…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer [Phase 1]
A Phase 1 trial to evaluate ovarian suppression using ZOLADEX 10.8 mg in premenopausal women with HR-positive, HER2-negative advanced breast…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases
Ongoing clinical trial assessing the role of pro-resolving lipid mediators in obesity-associated diseases, including breast cancer, with rec…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Effects of Neoadjuvant Prehabilitation on Post-Interventional Physical and Psychological Outcomes in Oncology Patients With Solid Tumors [NA]
This clinical trial investigates the impact of neoadjuvant prehabilitation on post-interventional physical and psychological outcomes in onc…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study
The EMPOWER Study (NCT06584396) is evaluating the mechanical properties of post-mastectomy skin flaps to estimate reconstruction risks and i…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer [NA]
Clinical trial update indicates a breast cancer study exploring the relationship between GDF-15 and treatment-related adverse events; the tr…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Comparison of Mean Duration of Analgesia Following the Administration of Bupivacaine With and Without Magnesium Sulphate in Ultrasound Guided Erector Spinae Plane Block in Modified Radical Mastectomy Patients [NA]
A completed clinical trial comparing mean duration of analgesia after using bupivacaine with or without magnesium sulfate in an ultrasound-g…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
A pilot study evaluating total-body PET imaging with FDA-approved radiotracers beyond 18F-FDG to image cancer. It aims to assess feasibility…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors [EARLY_Phase 1]
This early-phase (Phase 1) trial assesses the safety, dosimetry, and preliminary efficacy signals of the radiopharmaceutical 177Lu-INN805 in…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-low breast cancer patients with brain metastases, currently activ…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy [Phase 1, Phase 2]
Clinical trial update on BreastVAX combines radiation boost with immune checkpoint blockade therapy in breast cancer, currently in Phase 1/P…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer [NA]
This entry notes that a clinical trial investigating intraoperative electron radiotherapy for low-risk early breast cancer is currently recr…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer [EARLY_Phase 1]
Phase 1 trial evaluating topical or oral minoxidil for treating endocrine therapy-induced alopecia in patients with stage I-IV breast cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: CARE: Cancer Risk Perception and Women of Color
A completed clinical trial update for CARE, a study on cancer risk perception and women of color, with breast cancer as the condition studie…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial [NA]
This is a clinical trial update indicating a randomized study on meal timing during cancer treatment in Alaska is currently recruiting, invo…